Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
Use this MRKR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MRKR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MRKR SEC filings page. Lician reads the product cache first so this HTML stays unique to Marker Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MRKR income, balance, and cash tables.